Bionovate Technologies Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Feb '26 Feb 25, 2026	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017
Market Capitalization	0	20	59	1	9	1
Market Cap Growth	-99.99%	-67.06%	6256.95%	-89.29%	606.18%	53.43%
Enterprise Value	-	20	60	1	9	1
Last Close Price	0.00	0.95	1.00	6.00	56.00	412.65
PS Ratio	-	-	-	-	-	229.39
PB Ratio	0.00	-38.90	-149.81	-2.81	-28.17	-5.39
P/OCF Ratio	-	-	-	-	-	116.51
EV/Sales Ratio	-	-	-	-	-	227.52
Debt / Equity Ratio	-0.53	-0.55	-0.57	-0.68	-0.87	-0.19
Net Debt / Equity Ratio	-0.53	-0.55	-0.57	-0.68	-0.87	-0.19
Return on Capital Employed (ROCE)	9.20%	9.00%	8.30%	17.00%	38.40%	38.30%
Earnings Yield	-13587.87%	-0.54%	-0.21%	-22.35%	-19.95%	-26.17%
Buyback Yield / Dilution	80.53%	68.98%	-15943.66%	-145.73%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.